- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02532608
Infra-slow Oscillations During Sleep (SleepD-ISO)
Infra-slow Oscillations During Sleep, After Acute Sleep Deprivation and in Subjects With Restless Legs Syndrome/Periodic Leg Movements During Sleep (RLS/PLMS): an Explorative, Prospective, Monocentric, Observational Case-control and Interventional Study
Study Overview
Status
Intervention / Treatment
Detailed Description
Sleep is a highly dynamic process and during large parts of sleep the level of arousal fluctuates on a multi-second time scale between the sleep stage specific background and transient, phasic events that clearly arise from this background and constitute the microstructure of sleep. This microstructure is part of the dynamic physiological sleep regulation and at the same time reflects the instability of sleep, is critically involved in the pathophysiology of sleep and a determinant of the recuperative value of sleep and daytime performance.
Intriguingly, these sleep microstructural fluctuations are in a multi-second range that corresponds closely to the so-called infra-slow oscillations that are ubiquitous in the central nervous system. Infra-slow oscillations (0.01 - 0.1 Hz) have been observed in both humans and animals across brain structures and spatial scales in the dynamics of single unit firing rates, direct electrical potential fluctuations and oscillation amplitude modulations. The possibility to record these infra-slow oscillations on the level of the surface EEG with direct current (DC) or Full band (Fb) EEG offers a new approach to study the microstructure of sleep and characterise the full range of sleep-related EEG oscillations.
The objectives of this study are:
- to record and systematically characterise infra-slow oscillations during wake and all stages of sleep
- to explore the relationship between sleep infra-slow oscillations and microstructural events of sleep, in particular the cyclic alternating pattern
- to explore the effect of acute sleep deprivation on sleep infra-slow EEG activity
- to investigate infra-slow sleep EEG activity in patients with RLS/PLMS, common sleep disorders with prominent periodic arousals, heart rate activations, and leg movements
- to explore the relationship between infra-slow EEG oscillations and periodic events in movement and autonomic system activity in patients with RLS/PLMS.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ticino
-
Lugano, Ticino, Switzerland, 6903
- Neurocenter of Southern Switzerland
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria for all participants:
- Willingness to participate and written informed consent
- Aged 20 to 40 years at the time of screening
- Body mass index (BMI) ≤ 30
Additional inclusion criteria for subjects with RLS/PLMS:
- Either diagnosis of RLS and current IRLS score ≥ 15.
- Or frequent periodic leg movements during sleep
Exclusion criteria for all participants:
- Pregnancy or breast feeding at the time of screening
- Sleep related breathing disorders
- Current psychiatric disorders
- Current chronic treatment that may affect sleep.
- Any significant neurological disorder or other medical disease that may affect sleep.
- Any unstable medical condition.
Additional exclusion criteria for participants with RLS/PLMS:
- Current intake of dopaminergic drugs
- Current intake of other RLS relevant medication
- Intake of hypnotics
- Other significant sleep disorder except symptoms potentially related to RLS
Additional exclusion criteria for healthy participants:
- Any pharmacological treatment that may affect sleep and/or sleep related movement disorders
- Any clinically significant sleep disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Acute sleep deprivation
Registration of habitual sleep and sleep after sleep deprivation
|
Participants will stay awake for 36 hours
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Infra-slow frequency power
Time Frame: 36 hours
|
Average power (µV) in the infra-slow frequency range during wake and different stages of sleep derived from standard fast fourier transform and continuous wavelet transform.
|
36 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Stephany Fulda, PhD, Neurocenter of Southern Switzerland
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- EOC.NSI.LS.15.2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Restless Legs Syndrome
-
Walter Reed National Military Medical CenterWithdrawnEkbom Syndrome | Restless Legs Syndrome, | Restless Legs,United States
-
XenoPort, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
GlaxoSmithKlineCompletedRestless Legs Syndrome | Restless Legs Syndrome (RLS)United States
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs Syndrome
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)United States
-
Astellas Pharma IncCompletedRestless Legs Syndrome (RLS)Japan
-
Otsuka Pharmaceutical Co., Ltd.CompletedIdiopathic Restless Legs SyndromeJapan
-
UCB PharmaCompletedIdiopathic Restless Legs SyndromeGermany
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedIdiopathic Restless Legs SyndromeUnited States, Spain, Finland, Italy, Germany, Sweden, Austria, Netherlands, United Kingdom
-
American Regent, Inc.CompletedRestless Legs Syndrome (RLS)
Clinical Trials on Acute sleep deprivation
-
University of CopenhagenCompleted
-
Federal University of São PauloCompleted
-
Esther WerthCompletedIdiopathic Hypersomnia | Narcolepsy 1Switzerland
-
Yoav GimonRecruiting
-
Boston University Charles River CampusBrain & Behavior Research Foundation; One Mind; 1907 FoundationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
University Medical Center NijmegenCompletedAlzheimer DiseaseNetherlands
-
St Mary's University CollegeNot yet recruiting
-
Northwestern UniversityCompleted
-
Mclean HospitalCompleted